VINC
Geode Capital Management’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,285
| Closed | -$10.2K | – | 4583 |
|
|
2025
Q1 | $10.2K | Sell |
19,285
-222,232
| -92% | -$118K | ﹤0.01% | 4429 |
|
|
2024
Q4 | $63.5K | Sell |
241,517
-9,283
| -4% | -$2.44K | ﹤0.01% | 4198 |
|
|
2024
Q3 | $180K | Buy |
250,800
+20,015
| +9% | +$14.3K | ﹤0.01% | 3938 |
|
|
2024
Q2 | $187K | Buy |
230,785
+48,302
| +26% | +$39.1K | ﹤0.01% | 3932 |
|
|
2024
Q1 | $924K | Buy |
182,483
+28,452
| +18% | +$144K | ﹤0.01% | 3394 |
|
|
2023
Q4 | $182K | Hold |
154,031
| – | – | ﹤0.01% | 3980 |
|
|
2023
Q3 | $159K | Buy |
154,031
+17,153
| +13% | +$17.7K | ﹤0.01% | 4071 |
|
|
2023
Q2 | $178K | Hold |
136,878
| – | – | ﹤0.01% | 4095 |
|
|
2023
Q1 | $142K | Hold |
136,878
| – | – | ﹤0.01% | 4198 |
|
|
2022
Q4 | $139K | Sell |
136,878
-313
| -0.2% | -$318 | ﹤0.01% | 4268 |
|
|
2022
Q3 | $189K | Hold |
137,191
| – | – | ﹤0.01% | 4247 |
|
|
2022
Q2 | $181K | Sell |
137,191
-132,219
| -49% | -$174K | ﹤0.01% | 4334 |
|
|
2022
Q1 | $1.08M | Buy |
269,410
+23,941
| +10% | +$95.7K | ﹤0.01% | 3586 |
|
|
2021
Q4 | $2.5M | Buy |
245,469
+27,671
| +13% | +$282K | ﹤0.01% | 3270 |
|
|
2021
Q3 | $3.52M | Buy |
217,798
+67,026
| +44% | +$1.08M | ﹤0.01% | 3115 |
|
|
2021
Q2 | $1.96M | Buy |
150,772
+56,813
| +60% | +$738K | ﹤0.01% | 3273 |
|
|
2021
Q1 | $1.81M | Buy |
+93,959
| New | +$1.81M | ﹤0.01% | 3295 |
|